Saguaro Biosciences

📍 Quebec City, Canada🗓 Founded 2020👥 11 employees💰 Last funded May 2024
Biotechnology🌐 saguarobio.com
Website LinkedIn
Saguaro offers next-generation cell culture products that help scientists improve drug discovery success. ChromaLive is a first-of-a-kind non-toxic dye. It allows the generation of unique phenotypic signatures from microscopy images of cells, and the quantification of disease-relevant phenotypes like cellular apoptosis, stress, autophagy, and more. With its unique add-and-mix feature, ChromaLive is ideal for automation workflows, live cell painting, 3D cultures, weeks-long kinetic imaging, and patient-derived cells. We are passionate about new technologies that can improve human health. We believe that by making disruptive technologies available to drug developers around the globe, new therapies will become available to patients at a faster pace.
3
Total investors
1
Early stage
2
Mid stage
0
Late stage
2020
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
3
Investor activity2022–2024 · investors recorded per year
202212023120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Saguaro Biosciences?
Saguaro Biosciences has 3 investors on record on gritt.io, including 1 early-stage backers, 2 mid-stage.
When did Saguaro Biosciences last raise funding?
The most recent investment in Saguaro Biosciences recorded on gritt.io was in May 2024.
When was Saguaro Biosciences founded?
Saguaro Biosciences was founded in 2020.
What industry is Saguaro Biosciences in?
Saguaro Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Saguaro Biosciences based?
Saguaro Biosciences is headquartered in Quebec City, Canada.